cerrar
Tagged with Strategy

Ayman El Deeb – Cluster Head, Astellas Egypt
Ayman El Deeb, cluster head of Astellas Egypt, highlights how the Egyptian affiliate of Astellas has been performing since its establishment five…

Yuichi Yomasu – President, Daiichi Sankyo China
Yuichi Yomasu, president of Daiichi Sankyo China, shares his first impressions of the dynamic but complex Chinese market since he assumed position ten…

Tian Wee Ng – Managing Director (Asia-Pacific), Pierre…
Tian Wee Ng, managing director (Asia-Pacific) for Pierre Fabre Medicament, shares insight on how the business has evolved in the region, moving from…

Rogers Luo Yongqing – Global VP and General Manager…
Rogers Luo Yongqing, global VP and general manager (China), Gilead Sciences, shares the key accomplishments of Gilead in China with six innovative…

Min-Young Kim – General Manager, Ipsen Korea
Min-Young Kim, general manager at Ipsen Korea discusses her strategy to refocus the Korean affiliate away from the toxin market and towards oncology…

Hong Chow – General Manager, Roche Pharma China
Hong Chow, general manager of Roche Pharma China, shares Roche China’s incredible milestones over the past few years, including four pivotal…

Finn Søndergaard – CEO, Intsel Chimos, France
Finn Søndergaard, CEO of Intsel Chimos, shares the motivation behind the company’s two recent acquisitions of Diverchim and Centre Lab, and the new…

5 Tips for Success in Chinese Pharma
This is the first in a series of articles examining what it takes to be a country manager of a multinational pharma company in some of the world’s…

Pierre-Claude Fumoleau – General Manager, AbbVie France
Abbvie France’s Pierre-Claude Fumoleau outlines his strategic priorities for the affiliate, AbbVie’s unique corporate culture and ethos, and how…

Edouard Bieth – Managing Director, Tillotts Pharma France
Edouard Bieth, managing director of Tillotts Pharma in France, discusses the opportunities and challenges of opening an affiliate in the country and…

Jeong Woo Cho – CEO & President, SK Biopharmaceuticals…
SK Group, the second largest conglomerate in South Korea and renowned as a leader in energy, telecommunications, and the semiconductor business,…

Bong Gil Nam – Chairman & Owner, Pharmbio Korea
Bong Gil Nam, chairman and owner of Pharmbio Korea, offers his insights on his company’s importance in differentiating itself from the generic…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here